These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31930696)

  • 1. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
    Badia P; Ricci K; Gurria JP; Dasgupta R; Patel M; Hammill A
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28088. PubMed ID: 31930696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
    Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
    Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
    Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
    Leducq S; Caille A; Barbarot S; Bénéton N; Bessis D; Boccara O; Bursztejn AC; Chiaverini C; Dompmartin A; Droitcourt C; Gissot V; Goga D; Guibaud L; Herbreteau D; Le Touze A; Léauté-Labrèze C; Lorette G; Mallet S; Martin L; Mazereeuw-Hautier J; Phan A; Plantin P; Quéré I; Vabres P; Bourgoin H; Giraudeau B; Maruani A;
    Trials; 2019 Dec; 20(1):739. PubMed ID: 31847908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
    Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl.
    Cardis MA; DeKlotz CMC
    Pediatr Dermatol; 2018 Nov; 35(6):e406-e407. PubMed ID: 30152558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of topical rapamycin in the treatment of superficial lymphatic malformations.
    García-Montero P; Del Boz J; Baselga-Torres E; Azaña-Defez JM; Alcaraz-Vera M; Tercedor-Sánchez J; Noguera-Morel L; Vera-Casaño Á
    J Am Acad Dermatol; 2019 Feb; 80(2):508-515. PubMed ID: 30296533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.
    Sandbank S; Molho-Pessach V; Farkas A; Barzilai A; Greenberger S
    Acta Derm Venereol; 2019 Oct; 99(11):990-996. PubMed ID: 31304557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
    Gómez Sánchez A; Redondo Sedano JV; Pérez Alonso V; Martí Carrera ME; Baro Fernández M; Palencia Pérez SI; Gallego Herrero MC; Gómez Fraile A; Delgado Muñoz MD
    Cir Pediatr; 2020 Oct; 33(4):183-187. PubMed ID: 33016658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
    Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
    [No Abstract]   [Full Text] [Related]  

  • 12. Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.
    Czechowicz JA; Long-Boyle JR; Rosbe KW; Mathes EF; Frieden IJ; Shimano KA
    Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():48-51. PubMed ID: 29447818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Topical Sirolimus (Rapamycin) for the Treatment of Microcystic Lymphatic Malformations.
    Ivars M; Redondo P
    JAMA Dermatol; 2017 Jan; 153(1):103-105. PubMed ID: 27784048
    [No Abstract]   [Full Text] [Related]  

  • 14. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
    JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus for the treatment of complicated vascular anomalies in children.
    Hammill AM; Wentzel M; Gupta A; Nelson S; Lucky A; Elluru R; Dasgupta R; Azizkhan RG; Adams DM
    Pediatr Blood Cancer; 2011 Dec; 57(6):1018-24. PubMed ID: 21445948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
    Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
    Freixo C; Ferreira V; Martins J; Almeida R; Caldeira D; Rosa M; Costa J; Ferreira J
    J Vasc Surg; 2020 Jan; 71(1):318-327. PubMed ID: 31676179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
    Durand R; Reid JR; Belasco JB; Shellikeri S; Calle-Toro JS; Cahill AM; Srinivasan A
    AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
    [No Abstract]   [Full Text] [Related]  

  • 19. Generalized lymphatic anomaly successfully treated with long-term, low-dose sirolimus.
    Dvorakova V; Rea D; O'Regan GM; Irvine AD
    Pediatr Dermatol; 2018 Jul; 35(4):533-534. PubMed ID: 29582448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
    Ricci KW; Hammill AM; Mobberley-Schuman P; Nelson SC; Blatt J; Bender JLG; McCuaig CC; Synakiewicz A; Frieden IJ; Adams DM
    Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.